{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:24:58Z","timestamp":1790249098011,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":4052,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1111\/j.1538-7836.2011.04484.x","type":"journal-article","created":{"date-parts":[[2011,8,31]],"date-time":"2011-08-31T15:50:03Z","timestamp":1314805803000},"page":"2208-2214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Long\u2010term follow\u2010up of patients with portal vein thrombosis and myeloproliferative neoplasms"],"prefix":"10.1016","volume":"9","author":[{"given":"J.","family":"HOEKSTRA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.L.","family":"BRESSER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H.","family":"SMALBERG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.W.","family":"SPAANDER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.W.G.","family":"LEEBEEK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.L.A.","family":"JANSSEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.dld.2009.08.003","article-title":"Portal vein thrombosis, revisited","volume":"42","author":"Primignani","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0015","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.3748\/wjg.v12.i13.2115","article-title":"Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies","volume":"12","author":"Ogren","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0002-9343(92)90109-O","article-title":"Portal vein thrombosis: a review","volume":"92","author":"Cohen","year":"1992","journal-title":"Am J Med"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0025","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/gut.49.5.720","article-title":"Extrahepatic portal vein thrombosis: aetiology and determinants of survival","volume":"49","author":"Janssen","year":"2001","journal-title":"Gut"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0030","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-230X-7-34","article-title":"Portal vein thrombosis; risk factors, clinical presentation and treatment","volume":"7","author":"Sogaard","year":"2007","journal-title":"BMC Gastroenterol"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0035","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0016-5085(88)90567-7","article-title":"Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders","volume":"94","author":"Valla","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0040","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0045","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/hep.20591","article-title":"Risk factors for thrombophilia in extrahepatic portal vein obstruction","volume":"41","author":"Primignani","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/hep.23259","article-title":"European Network for Vascular Disorders of the Liver. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow\u2010up study","volume":"51","author":"Plessier","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0055","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1365-2257.2002.00444.x","article-title":"Portal or hepatic vein thrombosis as the first presentation of a myeloproliferative disorder in patients with normal peripheral blood counts","volume":"24","author":"McNamara","year":"2002","journal-title":"Clin Lab Haematol"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.leu.2404955","article-title":"Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point\u2010of\u2010care diagnostic algorithms","volume":"22","author":"Tefferi","year":"2008","journal-title":"Leukemia"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0065","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-123-9-199511010-00003","article-title":"Polycythemia vera: the natural history of 1213 patients followed for 20\u2003years","volume":"123","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0070","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1034\/j.1600-0609.2000.90236.x","article-title":"Incidence, clinical features and outcome of essential thrombocythaemia in a well defined geographical area","volume":"65","author":"Jensen","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0075","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1182\/blood-2009-08-238956","article-title":"Thrombosis in primary myelofibrosis: incidence and risk factors","volume":"115","author":"Barbui","year":"2010","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0080","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1200\/JCO.2005.07.062","article-title":"Vascular and neoplastic risk in a large cohort of patients with polycythemia vera","volume":"23","author":"Marchioli","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0085","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.1990.8.3.556","article-title":"Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia","volume":"8","author":"Cortelazzo","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0090","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3324\/haematol.12053","article-title":"Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments","volume":"93","author":"De Stefano","year":"2008","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0095","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/bjs.1800810923","article-title":"Patterns of portal vein occlusion and their aetiological significance","volume":"81","author":"Stringer","year":"1994","journal-title":"Br J Surg"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0100","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/gast.2001.21209","article-title":"Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy","volume":"120","author":"Condat","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0168-8278(92)90059-X","article-title":"Long\u2010term follow\u2010up study of adult patients with non\u2010cirrhotic obstruction of the portal system: comparison with cirrhotic patients","volume":"15","author":"Merkel","year":"1992","journal-title":"J Hepatol"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0110","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/j.1572-0241.2007.01477.x","article-title":"Prognostic factors in noncirrhotic patients with splanchnic vein thromboses","volume":"102","author":"Amitrano","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0115","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain\u2010of\u2010function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1538-7836.2006.02277.x","article-title":"The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis","volume":"5","author":"Colaizzo","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0125","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/hep.21435","article-title":"Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis","volume":"44","author":"Primignani","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0130","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/hep.21489","article-title":"JAK2 mutation: the best diagnostic tool for myeloproliferative disease in splanchnic vein thrombosis?","volume":"44","author":"Janssen","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0135","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1182\/blood-2007-11-125328","article-title":"The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases","volume":"111","author":"Kiladjian","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajh.10153","article-title":"Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia","volume":"71","author":"Ruggeri","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0145","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/jhep.2000.16597","article-title":"Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy","volume":"32","author":"Condat","year":"2000","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0150","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cgh.2008.07.031","article-title":"Portal hypertension\u2010related complications after acute portal vein thrombosis: impact of early anticoagulation","volume":"6","author":"Turnes","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2005.05.009","article-title":"Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"43","author":"de Franchis","year":"2005","journal-title":"J Hepatol"},{"key":"10.1111\/j.1538-7836.2011.04484.x_bb0160","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1056\/NEJMoa035572","article-title":"Efficacy and safety of low\u2010dose aspirin in polycythemia vera","volume":"350","author":"Landolfi","year":"2004","journal-title":"N Engl J Med"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2011.04484.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622074360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622074360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2011.04484.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:53:43Z","timestamp":1761533623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622074360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1538783622074360"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04484.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long\u2010term follow\u2010up of patients with portal vein thrombosis and myeloproliferative neoplasms","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04484.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}